# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-040280
Filing Date
2025-03-17
Accepted
2025-03-17 16:15:38
Documents
124
Period of Report
2024-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | fgen-20241231.htm iXBRL | 10-K | 4847517
2 | EX-10.5 | fgen-ex10_5.htm | EX-10.5 | 85162
3 | EX-10.6 | fgen-ex10_6.htm | EX-10.6 | 78091
4 | EX-23.1 | fgen-ex23_1.htm | EX-23.1 | 2601
5 | EX-31.1 | fgen-ex31_1.htm | EX-31.1 | 12205
6 | EX-31.2 | fgen-ex31_2.htm | EX-31.2 | 12426
7 | EX-32.1 | fgen-ex32_1.htm | EX-32.1 | 8171
| Complete submission text file | 0000950170-25-040280.txt |  | 20906153

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | fgen-20241231.xsd | EX-101.SCH | 3237235
127 | EXTRACTED XBRL INSTANCE DOCUMENT | fgen-20241231_htm.xml | XML | 3889294

Mailing Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133
Business Address 350 BAY STREET SUITE 100 #6009 SAN FRANCISCO CA 94133 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36740 | Film No.: 25744623
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)